US Stock MarketDetailed Quotes

JAZZ Jazz Pharmaceuticals

Watchlist

122.920
-3.480-2.75%

Close Mar 28 16:00 ET

122.920
0.0000.00%

Post 17:42 ET

7.47BMarket Cap14.21P/E (TTM)

Jazz Pharmaceuticals Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Jazz Pharmaceuticals Q4 2024 Earnings Date

Currency：USDFeb 25, 2025

	Estimate (YoY)	Actual (YoY)	Vs Estimate (% Chg)
Revenue	1.06B	1.09B	+30.06M
Beat Est.	+4.56%	+7.53%	+2.84%
EPS	2.71	3.11	+0.40
Beat Est.	+90.76%	+119.01%	+14.81%

Analyst Rating

Strong Buy

Mar 28, 2025

Jazz Pharmaceuticals Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 17 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual

Estimate

Date	Period	Revenue/Estimate	Earnings Call
--	2025/Q2	-- / 1.065B	--
--	2025/Q1	-- / 984.291M	--
Feb 25, 2025	2024/Q4	1.088B / 1.058B	--
Nov 6, 2024	2024/Q3	1.055B / 1.037B	--
Jul 31, 2024	2024/Q2	1.024B / 1.004B	--

DatePeriodRevenue/EstimateEarnings Call

--2025/Q2-- / 1.065B--

--2025/Q1-- / 984.291M--

Feb 25, 20252024/Q41.088B / 1.058B--

Nov 6, 20242024/Q31.055B / 1.037B--

Jul 31, 20242024/Q21.024B / 1.004B--

Unlock Free Earnings Estimates

Open Account

Jazz Pharmaceuticals Earnings Reports

Jazz Pharmaceuticals | 10-K: FY2024 Annual Report

Feb 26 07:36 ET

Jazz Pharmaceuticals | 8-K: Jazz Pharmaceuticals Announces Full Year and Fourth Quarter 2024 Financial Results and Provides 2025 Financial Guidance

Feb 25 16:13 ET

Jazz Pharmaceuticals | 10-Q: Q3 2024 Earnings Report

Nov 7, 2024 07:33 ET

Jazz Pharmaceuticals | 8-K: Jazz Pharmaceuticals Announces Third Quarter 2024 Financial Results

Nov 6, 2024 16:08 ET